Is Island Pharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Island Pharmaceuticals Ltd (ILA.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Island Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Island Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Island Pharmaceuticals Ltd?

Muslim investors may consider investing in Island Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Island Pharmaceuticals Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Island Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Island Pharmaceuticals Ltd updated?

The Shariah compliance status of Island Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Island Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Island Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Island Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ILA.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: October 20, 2025

Report Source: 2025 Annual Report

Island Pharmaceuticals Ltd. Stock Analysis ILA.AX

Australia Health Care Micro Cap Report: 2025 Annual

Island Pharmaceuticals Ltd. is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-04-13. The firm is focused on areas of unmet need for antiviral therapeutics to address infectious diseases. Its lead asset is ISLA-101, a drug with a safety profile being repurposed for the prevention and treatment of dengue2 fever and other mosquito (or vector) borne diseases. ISLA-101 has been shown to have activity against all four strains of dengue virus as well as other flaviviruses such as Zika virus, West Nile virus, and Yellow Fever virus, as well as Chikungunya virus. While ISLA-101 is an oral formulation, the Company is also considering alternative formulations, including a long-acting oral formulation and intravenous formulations for severe dengue infections. The firm operates a single segment, being research and development activities principally in the geographic regions of Australia and the United States. Its subsidiary is Isla Pharmaceuticals Inc.

Key Statistics of Island Pharmaceuticals Ltd (ILA.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.33AUD0.36

Today's Open

AUD0.33

Volume

212.83K

P/E Ratio (TTM)

52 Week Range

AUD0.13AUD0.63

Market Cap

109.49M

Avg. Volume

155.79K

Dividend Yield

Financial Metrics & Statements of Island Pharmaceuticals Ltd (ILA.AX)

FAQ's for Island Pharmaceuticals Ltd (ILA.AX)

According to Musaffa’s Shariah screening methodology, Island Pharmaceuticals Ltd (ILA.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.